The efficacy (AUC) of serum CEA and CA19-9 in distinguishing HCC and CCA was also lower than the efficacy of AFP, AFP-L3%, PIVKA-II and the diagnostic models in distinguishing HCC and non-HCC (Table 3). The gene discussed is CEACAM5; the disease is cholangiocarcinoma.